DK216877A - Fremgangsmade til fremstilling af 3,7-disubstituerede cefalosporiner - Google Patents

Fremgangsmade til fremstilling af 3,7-disubstituerede cefalosporiner

Info

Publication number
DK216877A
DK216877A DK216877A DK216877A DK216877A DK 216877 A DK216877 A DK 216877A DK 216877 A DK216877 A DK 216877A DK 216877 A DK216877 A DK 216877A DK 216877 A DK216877 A DK 216877A
Authority
DK
Denmark
Prior art keywords
cephalosporins
disubstituted
procedure
preparation
disubstituted cephalosporins
Prior art date
Application number
DK216877A
Other languages
Danish (da)
English (en)
Inventor
G Palamidessi
F Zarini
G Franceschi
G Schioppacassi
F Arcamone
Original Assignee
Farmaceutici Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutici Italia filed Critical Farmaceutici Italia
Publication of DK216877A publication Critical patent/DK216877A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK216877A 1976-05-21 1977-05-18 Fremgangsmade til fremstilling af 3,7-disubstituerede cefalosporiner DK216877A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB21032/76A GB1579532A (en) 1976-05-21 1976-05-21 Cephalosporins

Publications (1)

Publication Number Publication Date
DK216877A true DK216877A (da) 1977-11-22

Family

ID=10156029

Family Applications (1)

Application Number Title Priority Date Filing Date
DK216877A DK216877A (da) 1976-05-21 1977-05-18 Fremgangsmade til fremstilling af 3,7-disubstituerede cefalosporiner

Country Status (22)

Country Link
US (1) US4148996A (xx)
JP (1) JPS52142093A (xx)
AT (1) AT355719B (xx)
AU (1) AU509448B2 (xx)
BE (1) BE854845A (xx)
CA (1) CA1102790A (xx)
CH (1) CH639095A5 (xx)
CS (1) CS199676B2 (xx)
DE (1) DE2722666C2 (xx)
DK (1) DK216877A (xx)
FR (1) FR2424922A1 (xx)
GB (1) GB1579532A (xx)
GR (1) GR73013B (xx)
HU (1) HU174072B (xx)
IL (1) IL52123A (xx)
NL (1) NL7705262A (xx)
NO (1) NO771744L (xx)
NZ (1) NZ184110A (xx)
SE (1) SE433851B (xx)
SU (1) SU799669A3 (xx)
YU (1) YU123077A (xx)
ZA (1) ZA772859B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017004077A1 (en) * 2015-06-29 2017-01-05 Duke University Antimicrobial prochelators to target drug-resistant bacteria and methods of making and using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL38099A (en) * 1970-12-17 1976-01-30 Smith Kline French Lab 3-heterocyclyl thiomethylcephalosporins
US4007173A (en) * 1973-05-07 1977-02-08 Smithkline Corporation α-amino-α-(ureidophenyl)acetamidocephalosporins
DE2359544A1 (de) * 1973-11-29 1975-10-30 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
US3960849A (en) * 1974-03-13 1976-06-01 E. R. Squibb & Sons, Inc. Amino-1,2,4-oxadiazolyl-3-acetyl cephalosporins
DE2512284A1 (de) * 1974-03-28 1975-10-09 Fujisawa Pharmaceutical Co Cephalosporansaeurederivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel

Also Published As

Publication number Publication date
NO771744L (no) 1977-11-22
AU509448B2 (en) 1980-05-15
ZA772859B (en) 1978-04-26
GR73013B (xx) 1984-01-25
SU799669A3 (ru) 1981-01-23
YU123077A (en) 1982-10-31
AT355719B (de) 1980-03-25
SE7705934L (sv) 1977-11-22
DE2722666C2 (de) 1982-04-15
CA1102790A (en) 1981-06-09
FR2424922B1 (xx) 1983-07-08
AU2507177A (en) 1978-11-16
FR2424922A1 (fr) 1979-11-30
ATA348977A (de) 1979-08-15
BE854845A (fr) 1977-11-21
CS199676B2 (en) 1980-07-31
GB1579532A (en) 1980-11-19
IL52123A (en) 1980-11-30
HU174072B (hu) 1979-10-28
US4148996A (en) 1979-04-10
JPS52142093A (en) 1977-11-26
DE2722666A1 (de) 1977-12-01
CH639095A5 (de) 1983-10-31
NL7705262A (nl) 1977-11-23
SE433851B (sv) 1984-06-18
IL52123A0 (en) 1977-07-31
NZ184110A (en) 1979-08-31

Similar Documents

Publication Publication Date Title
DK30277A (da) Fremgangsmade til fremstilling af substituerede phenylamidiner
DK118277A (da) Fremgangsmade til fremstilling af n-5-tetrazololyl)-4-oxo-4h-pyrimido (2,1-b)benzothiazol-3-carboxamider
DK244577A (da) Fremgangsmade til fremstilling af hydantoinderivater
DK243477A (da) Fremgangsmade til fremstilling af 10,19-dihydrovitamin d forbindelser
DK91277A (da) Fremgangsmade til fremstilling af cephalosporiner
DK554076A (da) Fremgangsmade til fremstilling af 3,4i-dideoxykanamycin ]
DK164376A (da) Fremgangsmade til fremstilling af 3,4-dihydrospiro-2h-1,3-benzoxaziner
DK187577A (da) Fremgangsmade til fremstilling af 1,4-benzodioxsnderivater
DK184377A (da) Fremgangsmade til fremstilling af indazolyl-(4)-oxy-propanolaminer
SE436026B (sv) Forfarande for framstellning av 13,14-dehydroprostaglandiner
DK185977A (da) Fremgangsmade til fremstilling af 1,3-dihydroheteroarylspiro (isobenzofuraner)
DK144377A (da) Fremgangsmade til fremstilling af acylcyanider
RO75589A (ro) Procedeu pentru prepararea 2,6-metan-2h-1-benzoxocinei
DK88777A (da) Fremgangsmade til fremstilling af substituerede azapuriner
SE7707125L (sv) Forfarande for framstellning av 7-(alfa-(2,3, - dihydro-2-oxo-1h- bensimidazol -1- ylkarbomyl-amino) arylacetamido ) cefalasporiner
DK216977A (da) Fremgangsmade til fremstilling af imidazobenzoxaziner
DK144277A (da) Fremgangsmade til fremstilling af acylcyanider
DK126077A (da) Fremgangsmade til fremstilling af 2,6-di-tert-butylphenol
DK368877A (da) Fremgangsmaade til fremstilling af aryloxy-1-amino-3-propanoler-2.
DK575277A (da) Fremgangsmaade til fremstilling af basisk substituerede 0-propyloximer
DK566277A (da) Fremgangsmaade til fremstilling af 1-aminoalkyl3,4-diphenyl-1h-pyrazoler
DK196577A (da) Fremgangsmade til fremstilling af kolecystokinin-pankreozymin-oktapeptidamidsulfatester
DK345477A (da) Fremgangsmaade til fremstilling af 2,3-dichloranisol
DK216877A (da) Fremgangsmade til fremstilling af 3,7-disubstituerede cefalosporiner
DK149803C (da) Fremgangsmaade til fremstilling af 1,2-dichlorethan